首页> 美国卫生研究院文献>other >Toward Discovering New Anti-Cancer Agents Targeting Topoisomerase IIα: A Facile Screening Strategy Adaptable to High Throughput Platform
【2h】

Toward Discovering New Anti-Cancer Agents Targeting Topoisomerase IIα: A Facile Screening Strategy Adaptable to High Throughput Platform

机译:寻求发现针对拓扑异构酶IIα的新抗癌药:一种适用于高通量平台的简便筛选策略

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Topoisomerases are a family of vital enzymes capable of resolving topological problems in DNA during various genetic processes. Topoisomerase poisons, blocking reunion of cleaved DNA strands and stabilizing enzyme-mediated DNA cleavage complex, are clinically important antineoplastic and anti-microbial agents. However, the rapid rise of drug resistance that impedes the therapeutic efficacy of these life-saving drugs makes the discovering of new lead compounds ever more urgent. We report here a facile high throughput screening system for agents targeting human topoisomerase IIα (Top2α). The assay is based on the measurement of fluorescence anisotropy of a 29 bp fluorophore-labeled oligonucleotide duplex. Since drug-stabilized Top2α-bound DNA has a higher anisotropy compared with free DNA, this assay can work if one can use a dissociating agent to specifically disrupt the enzyme/DNA binary complexes but not the drug-stabilized ternary complexes. Here we demonstrate that NaClO4, a chaotropic agent, serves a critical role in our screening method to differentiate the drug-stabilized enzyme/DNA complexes from those that are not. With this strategy we screened a chemical library of 100,000 compounds and obtained 54 positive hits. We characterized three of them on this list and demonstrated their effects on the Top2α–mediated reactions. Our results suggest that this new screening strategy can be useful in discovering additional candidates of anti-cancer agents.
机译:拓扑异构酶是一类重要的酶,能够解决各种遗传过程中DNA的拓扑问题。拓扑异构酶毒物,可阻断裂解的DNA链的团聚并稳定酶介导的DNA裂解复合物,是临床上重要的抗肿瘤药和抗微生物药。但是,耐药性的迅速上升阻碍了这些救生药物的治疗功效,这使得发现新的先导化合物变得更加紧迫。我们在这里报告了针对人拓扑异构酶IIα(Top2α)的药剂的便捷高通量筛选系统。该测定基于29 bp荧光团标记的寡核苷酸双链体的荧光各向异性的测量。由于与游离DNA相比,药物稳定化的与Top2α结合的DNA具有更高的各向异性,因此,如果可以使用解离剂特异性破坏酶/ DNA二元复合物,而不破坏药物稳定化的三元复合物,则该测定法可以工作。在这里,我们证明了离液剂NaClO4在我们的筛选方法中起着至关重要的作用,以区分药物稳定的酶/ DNA复合物与未稳定的酶/ DNA复合物。通过这种策略,我们筛选了100,000种化合物的化学文库,并获得54个阳性结果。我们表征了该列表中的三个,并证明了它们对Top2α介导的反应的影响。我们的结果表明,这种新的筛选策略可用于发现其他抗癌药物候选物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号